TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16564374

Group type: EXPERIMENTAL
Intervention: Multilevel surgical protocol including uvulaflap, tonsillectomy, hyoid suspension, and radiofrequency treatment of the tongue base (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgery without hyoid suspension (group B)
Number of subjects: 60
Study: 12771457

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 200
Study: 10709814

Group type: EXPERIMENTAL
Intervention: Postural tremor with no visual feedback
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Tremor in Parkinson's disease
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Finger flexions
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Time domain characteristics
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Acceleration data
Number of subjects: 51
Study: 9357885

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine at concentrations of 0.3 ng/ml and 0.6 ng/ml
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control values (baseline)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 9
Study: 8096945

Group type: EXPERIMENTAL
Intervention: Leukotriene LTE4 inhalation
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 4
Study: 3803701

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate spray (2.5 mg, 2 squirts, administered 2 min before testing)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 10
Study: 29927891

Group type: EXPERIMENTAL
Intervention: Sled towing with 35% reduction in velocity
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sled towing with 55% reduction in velocity
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline unresisted 20‐m sprints
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unresisted 20‐m sprints at 2, 4, 6, 8, 12, and 16 minutes
Number of subjects: 12

Group type: COMPARATOR
Intervention: EMG assessment
Number of subjects: 12
Study: 29571817

Group type: EXPERIMENTAL
Intervention: mOPV2 doses at 1 week interval (n=191)
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: mOPV2 doses at 2 weeks interval (n=191)
Number of subjects: 760

Group type: COMPARATOR
Intervention: mOPV2 doses at 4 weeks interval (n=188)
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: mOPV2 doses at 4 weeks interval plus IPV (n=190)
Number of subjects: 760
Study: 27530156

Group type: EXPERIMENTAL
Intervention: Group nurse-led consultations (4 group sessions and 1 individual consultation)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Usual care (individual consultations)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Group nurse-led consultations
Number of subjects: 331
Study: 26652724

Group type: EXPERIMENTAL
Intervention: 30 min of aerobic exercise
Number of subjects: 46

Group type: COMPARATOR
Intervention: Reading control
Number of subjects: 46
Study: 23748210

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug (AAD) therapy
Number of subjects: 154

Group type: COMPARATOR
Intervention: Reablation (repulmonary vein isolation)
Number of subjects: 154
Study: 19788955

Group type: EXPERIMENTAL
Intervention: Self-report by phone
Number of subjects: 140

Group type: COMPARATOR
Intervention: Home inventory
Number of subjects: 140
Study: 18802911

Group type: EXPERIMENTAL
Intervention: Minimally invasive dual-incision approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard posterolateral approach
Number of subjects: 40
Study: 16626384

Group type: EXPERIMENTAL
Intervention: Skin-lightening gel with ultrasound
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Skin-lightening gel treatment
Number of subjects: 60
Study: 12694345

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study: 10024108

Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion (20% of total calories)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion + 1.8 g/day EPA
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion
Number of subjects: 23

Group type: COMPARATOR
Intervention: Fat-free TPN (Control)
Number of subjects: 23
Study: 7775683

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavioral management group (Control)
Number of subjects: 0
Study: 2279535

Group type: EXPERIMENTAL
Intervention: PGI2 (5 ng/kg/min i.v.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PGE1 (1 ng/kg/min i.a.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of PGI2 and PGE1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second infusion of the same compound
Number of subjects: 0
Study: 6101677

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) 60 microgram/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31566810

Group type: EXPERIMENTAL
Intervention: Avatar application
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 70
Study: 29589050

Group type: EXPERIMENTAL
Intervention: App-based feedback-controlled active muscle training programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (identical postoperative protocol without active muscle training)
Number of subjects: 60
Study: 27897018

Group type: EXPERIMENTAL
Intervention: Adjustable single-incision (Ajust) tape
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard transobturator midurethral sling (TVT-O)
Number of subjects: 100
Study: 25131348

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) with a goal of ≥7% reduction in baseline weight
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Higher fiber intake (8.3 g/day increase)
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Higher baseline intake of fruit
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Higher baseline intake of high-fiber grain and cereal
Number of subjects: 1701

Group type: COMPARATOR
Intervention: Diabetes support and education (control arm)
Number of subjects: 1701
Study: 23021325

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1261

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1261
Study: 20176418

Group type: EXPERIMENTAL
Intervention: Individualized nutritional support
Number of subjects: 124

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 124
Study: 17270513

Group type: EXPERIMENTAL
Intervention: Twice-weekly supervised pulmonary rehabilitation (2 sessions/week)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Once-weekly supervised pulmonary rehabilitation (1 session/week)
Number of subjects: 91
Study: 16093405

Group type: EXPERIMENTAL
Intervention: Water-washed soy protein concentrate
Number of subjects: 159

Group type: COMPARATOR
Intervention: Milk-protein based control
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both groups during run-in period
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both groups during intervention period
Number of subjects: 159
Study: 12174159

Group type: EXPERIMENTAL
Intervention: Methenamine hippurate (1 g Hiprex, twice daily for 5 days)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 9869506

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg, t.d.s.)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lisinopril (10 mg, o.d.)
Number of subjects: 34
Study: 7989628

Group type: EXPERIMENTAL
Intervention: 5 percent EMLA cream
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5 percent lidocaine ointment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2919600

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Aluminum hydroxide
Number of subjects: 21
Study: 29154368

Group type: EXPERIMENTAL
Intervention: naltrexone
Number of subjects: 426

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 426
Study: 28793967

Group type: EXPERIMENTAL
Intervention: Experimental arm (advanced type 2 specialty clinic model)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control arm (standard endocrinology clinics)
Number of subjects: 60
Study: 25697763

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) therapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cryo-ultrasound (cryo-US) therapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 23427839

Group type: EXPERIMENTAL
Intervention: Group treatment using manualized hypnosis
Number of subjects: 85

Group type: COMPARATOR
Intervention: Individual treatment using manualized hypnosis
Number of subjects: 85
Study: 21297442

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo-saline
Number of subjects: 120
Study: 19363107

Group type: EXPERIMENTAL
Intervention: Color My Pyramid nutrition education program
Number of subjects: 126
Study: 16834789

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (50 mg kg‐1 in 100 mL of isotonic saline over 20 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (saline over the same period)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 15320640

Group type: EXPERIMENTAL
Intervention: Traditional plus stretching (S)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Traditional (T) warm-up
Number of subjects: 83
Study: 11308246

Group type: EXPERIMENTAL
Intervention: Self-report questionnaire (GHQ12) completed by patients prior to consultation
Number of subjects: 2297

Group type: EXPERIMENTAL
Intervention: Doctors' visual analogue scales rating patients' distress after consultation
Number of subjects: 2297
Study: 9305483

Group type: EXPERIMENTAL
Intervention: Oral elemental diet (Peptamen, Clintec, USA) for 2 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Corticosteroids for 2 weeks
Number of subjects: 22
Study: 7584283

Group type: EXPERIMENTAL
Intervention: Graphemic encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic encoding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard indirect test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct test
Number of subjects: 0
Study: 2572741

Group type: EXPERIMENTAL
Intervention: Oleic acid (3.5 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Stearic acid
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Corn oil (30 g, predominantly diunsaturated)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Olive oil (30 g, predominantly monounsaturated)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Suet (30 g, predominantly saturated)
Number of subjects: 6
Study: 979915

Group type: EXPERIMENTAL
Intervention: POMP (methotrexate, 6‐MP, vincristine, prednisone)
Number of subjects: 41

Group type: COMPARATOR
Intervention: COAP (cytosine arabinoside, cytoxan, vincristine, prednisone)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Responders to chemotherapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Both induction regimens
Number of subjects: 41
Study: 30711603

Group type: EXPERIMENTAL
Intervention: Conventional method (C) - custom tray with impression compound and silicone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Simplified method (S) - stock tray with alginate
Number of subjects: 24
Study: 29282108

Group type: EXPERIMENTAL
Intervention: E-bicycle with trailer for child transportation (3 months access)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Longtail bicycle (3 months access)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Regular bicycle with trailer (3 months access)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual transportation and PA habits (control group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All interventions (combined)
Number of subjects: 36
Study: 24903002

Group type: EXPERIMENTAL
Intervention: MDMA (125 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylphenidate (60 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 22104255

Group type: EXPERIMENTAL
Intervention: Respiratory‐muscle exercises for 10 min thrice a week for 4 wk
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Respiratory‐muscle exercises
Number of subjects: 26
Study: 20216107

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18612060

Group type: EXPERIMENTAL
Intervention: Multicomponent quality improvement intervention (performance feedback, peer‐to‐peer education, practice facilitator, IT support)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Performance feedback and benchmarking (control)
Number of subjects: 24
Study: 15679714

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 4308
Study: 12433007

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Medication (sertraline)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Combination of exercise and medication
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 156
Study: 11196124

Group type: EXPERIMENTAL
Intervention: felodipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 7613099

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Paroxetine 40 mg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Amitriptyline 75 mg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 10294790

Group type: COMPARATOR
Intervention: Standard message (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard message combined with action plans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard plus action plan message with wellness thinking information
Number of subjects: 0
Study: 271585

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory agents
Number of subjects: 0
Study: 31314925

Group type: EXPERIMENTAL
Intervention: PF-06648671
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30718126

Group type: EXPERIMENTAL
Intervention: Interval cytoreductive surgery (ICS) + hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interval cytoreductive surgery (ICS)
Number of subjects: 0
Study: 28282558

Group type: EXPERIMENTAL
Intervention: SRP+Nd:YAG laser
Number of subjects: 28

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 28
Study: 26066621

Group type: EXPERIMENTAL
Intervention: Bipolar tissue sealer
Number of subjects: 32

Group type: COMPARATOR
Intervention: Suture ligation (2/0 polyglactin sutures)
Number of subjects: 32
Study: 23257667

Group type: EXPERIMENTAL
Intervention: Bright Futures Oral Health curriculum
Number of subjects: 143
Study: 22338921

Group type: EXPERIMENTAL
Intervention: Circuit box jumping exercise program
Number of subjects: 57
Study: 19351801

Group type: EXPERIMENTAL
Intervention: Caffeine (150 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine plus zolpidem (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine plus trazodone (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16613915

Group type: EXPERIMENTAL
Intervention: Trained patient educators (PEs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Doctors
Number of subjects: 50
Study: 15229817

Group type: EXPERIMENTAL
Intervention: Aprotinin (1 Mio KIE) administered at the latest 15 min before delivery
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal deliveries without aprotinin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Cesarean sections with aprotinin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cesarean sections without aprotinin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Factor VIII and partial thromboplastin time (PTT) in all study groups
Number of subjects: 84
Study: 11505787

Group type: EXPERIMENTAL
Intervention: Echinaceae purpureae herba (Echinacin, EC31J0)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9289950

Group type: EXPERIMENTAL
Intervention: Cefotetan prophylaxis
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (no prophylaxis)
Number of subjects: 43
Study: 8515329

Group type: EXPERIMENTAL
Intervention: Ambulatory/inpatient rotation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Exclusive inpatient training
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ambulatory training
Number of subjects: 75
Study: 2952619

Group type: COMPARATOR
Intervention: Vasopressin derivative (daily for 10 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Single dose of vasopressin derivative
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Vasopressin treatment (three times weekly for 6 weeks in rats)
Number of subjects: 32
Study: 29373503

Group type: EXPERIMENTAL
Intervention: Regular activity breaks (RAB) - 2 min of walking every 30 min
Number of subjects: 36

Group type: COMPARATOR
Intervention: Prolonged sitting (SIT)
Number of subjects: 36
Study: 26821240

Group type: EXPERIMENTAL
Intervention: 5% lidocaine-medicated plasters
Number of subjects: 265
Study: 25024650

Group type: EXPERIMENTAL
Intervention: Restorative Sleep Questionnaire (RSQ) administered to patients with primary insomnia assessed by polysomnography (PSG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restorative Sleep Questionnaire (RSQ) administered to healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restorative Sleep Questionnaire (RSQ) administered to subjects with NRS complaints
Number of subjects: 0
Study: 22613634

Group type: EXPERIMENTAL
Intervention: Recruitment maneuvers (RMs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1 or fewer RMs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 RMs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ≥ 3 RMs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extrapulmonary ALI
Number of subjects: 0
Study: 20511208

Group type: EXPERIMENTAL
Intervention: 50 mg sumatriptan
Number of subjects: 749

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 749
Study: 18806540

Group type: EXPERIMENTAL
Intervention: Pain management based on clinical experience
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current large-scale studies of pemphigus
Number of subjects: 0
Study: 15647341

Group type: EXPERIMENTAL
Intervention: Ultradian blood pressure rhythms (12, 8, and 6 h)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Circadian blood pressure rhythms
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Conventional BP dipping parameters (day/night difference, day/night ratio)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 214
Study: 12532112

Group type: COMPARATOR
Intervention: Cat dander extract containing 0.6 microg Fel d 1
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cat dander extract containing 3.0 microg Fel d 1
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cat dander extract containing 15.0 microg Fel d 1
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 10806258

Group type: EXPERIMENTAL
Intervention: Rollerball endometrial ablation
Number of subjects: 255

Group type: COMPARATOR
Intervention: Uterine balloon endometrial ablation
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Both procedures (rollerball and balloon)
Number of subjects: 255
Study: 8649563

Group type: EXPERIMENTAL
Intervention: 8 MIU rIFNbeta
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 1.6 MIU rIFNbeta
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: rIFNbeta (unspecified dose)
Number of subjects: 34
Study: 1517642

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Meperidine
Number of subjects: 50
Study: 6828559

Group type: EXPERIMENTAL
Intervention: Level side lying position with percussion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Head-down side lying position with percussion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Level side lying position without percussion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Head-down side lying position without percussion
Number of subjects: 40
Study: 31401049

Group type: COMPARATOR
Intervention: IV ketamine (7 mg kg‐1) and IV midazolam (0.25 mg kg‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral fluconazole (5 mg kg‐1) administered 12 and 24 hours prior to ketamine-midazolam
Number of subjects: 12
Study: 29791970

Group type: EXPERIMENTAL
Intervention: HRC in hypoxia (HRChyp)
Number of subjects: 28

Group type: COMPARATOR
Intervention: HRC in normoxia (HRCnorm)
Number of subjects: 28
Study: 25098253

Group type: EXPERIMENTAL
Intervention: Mobile phone coaching and individualized web portal
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 118
Study: 24679401

Group type: EXPERIMENTAL
Intervention: Dominant (expanded) nonverbal posture
Number of subjects: 81

Group type: COMPARATOR
Intervention: Neutral nonverbal posture
Number of subjects: 81

Group type: COMPARATOR
Intervention: Submissive (constricted) nonverbal posture
Number of subjects: 81
Study: 22337532

Group type: EXPERIMENTAL
Intervention: VDW chemotherapy data for trastuzumab
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: VDW chemotherapy data for anthracyclines
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: VDW chemotherapy data for other chemotherapy
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: VDW mean doses for trastuzumab
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: VDW mean doses for anthracyclines
Number of subjects: 400
Study: 19818174

Group type: EXPERIMENTAL
Intervention: Coartem Dispersible (dispersible formulation of artemether/lumefantrine)
Number of subjects: 899

Group type: COMPARATOR
Intervention: Crushed AL tablets (control)
Number of subjects: 899